These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9794785)

  • 1. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope.
    Mort JS; Magny MC; Lee ER
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):491-4. PubMed ID: 9794785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate.
    Lee ER; Lamplugh L; Leblond CP; Mordier S; Magny MC; Mort JS
    Anat Rec; 1998 Sep; 252(1):117-32. PubMed ID: 9737748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
    Fosang AJ; Neame PJ; Last K; Hardingham TE; Murphy G; Hamilton JA
    J Biol Chem; 1992 Sep; 267(27):19470-4. PubMed ID: 1326552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.
    Fosang AJ; Last K; Gardiner P; Jackson DC; Brown L
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):337-43. PubMed ID: 7544117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
    J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B.
    Nguyen Q; Mort JS; Roughley PJ
    Biochem J; 1990 Mar; 266(2):569-73. PubMed ID: 2317204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
    Sandy JD; Verscharen C
    Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation.
    Hou WS; Li Z; Büttner FH; Bartnik E; Brömme D
    Biol Chem; 2003 Jun; 384(6):891-7. PubMed ID: 12887056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
    Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of catabolism of aggrecan by articular cartilage.
    Ilic MZ; Handley CJ; Robinson HC; Mok MT
    Arch Biochem Biophys; 1992 Apr; 294(1):115-22. PubMed ID: 1550337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants.
    Fosang AJ; Last K; Stanton H; Weeks DB; Campbell IK; Hardingham TE; Hembry RM
    J Biol Chem; 2000 Oct; 275(42):33027-37. PubMed ID: 10882746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage.
    Nguyen Q; Liu J; Roughley PJ; Mort JS
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):143-7. PubMed ID: 1883326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
    Bayne EK; MacNaul KL; Donatelli SA; Christen A; Griffin PR; Hoerrner LA; Calaycay JR; Ayala JM; Chapman K; Hagmann W
    Arthritis Rheum; 1995 Oct; 38(10):1400-9. PubMed ID: 7575690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides.
    Seyfried NT; McVey GF; Almond A; Mahoney DJ; Dudhia J; Day AJ
    J Biol Chem; 2005 Feb; 280(7):5435-48. PubMed ID: 15590670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggrecan-versican-neurocan family proteoglycans.
    Margolis RU; Margolis RK
    Methods Enzymol; 1994; 245():105-26. PubMed ID: 7539091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.